Your partner this blood cancer awareness month

Oncology | Blood cancer

Your partner this blood cancer awareness month

Blood cancer is an overarching term for cancers affecting the blood, bone marrow and lymphatic system. There are over 100 different types of blood cancer, each involving different key genes.

September is Blood Cancer Awareness month. At QIAGEN, we understand that laboratories need a partner that can support their diagnostic work, cancer research and clinical decision support in oncohematology. Read below to see how partnering with QIAGEN helped these labs rise to the challenges they faced.

Blood Cancer Sample to Insight Series

Your partner this blood cancer awareness month
Munyoro Guvamatanga, Advanced Biomedical Scientist, Princess Elizabeth Hospital, Guernsey, UK
Anna Tarasewicz, Specialist Biomedical Scientist in Haematology & Blood Transfusion at BSUH, UK
Improved leukemia patient care with molecular analysis
"We needed a cost-effective onco-hematology solution with shorter turnaround times and improved sensitivity versus outsourcing to the external laboratory. The solution had to be robust, easy to implement and scale-up, adaptable to our existing platforms and covered by NEQAS for external quality assessment."

Munyoro Guvamatanga, Advanced Biomedical Scientist, Princess Elizabeth Hospital, Guernsey, UK

European biomedical lab experience
Learn how a European laboratory partnered with QIAGEN to implement an end-to-end solution for JAK2 V617F and CALR testing, using a single blood sample.
Maximize blood cancer clinical research with flexible NGS panels
"The testing workflow also needed to be compatible with GC-rich genomic regions, providing 100% coverage of genes rich in GC content such as CEBPA. Accurate detection of large insertions/deletions and the internal tandem duplications (ITD) of the FLT3 gene is also a major factor for us. QIAseq panels were the optimal solution for all of these testing needs."

Dr. Friedel Nollet, Molecular Biologist, AZ Sint-Jan Brugge, Belgium

Maximize blood cancer clinical research with  flexible NGS panels
Dr. Friedel Nollet, Molecular Biologist, AZ Sint-Jan Brugge, Belgium
Clinical research lab experience
Discover how flexible NGS panels have streamlined clinical cancer research, with higher throughput and efficiency, to maintain a laboratory’s competitive edge.
Dr. Frederick K. Racke, Medical Director
Dr. Frederick K. Racke, Medical Director of Hematology/Oncology and Coagulation, Quest Diagnostics
Precision insights for rapid assay interpretation
“The Quest/QIAGEN partnership has allowed us to provide rapid and insightful information to our clinical colleagues, allowing us to better take care of their patients.”

Dr. Frederick K. Racke, Medical Director of Hematology/Oncology and Coagulation, Quest Diagnostics

North American biomedical lab experience
Discover how partnering with QIAGEN has helped enable a laboratory to quickly build patient-specific reports with the latest diagnostic, prognostic and therapeutic information.
Sue Branford – a leading inspirational scientist
“Cancer touches many people at some stage during their lifetime and being involved in cancer research is a privilege and rewarding on many fronts. I have been fortunate that my research has translated into the clinic to directly benefit patients and influence management decisions.”

Sue Branford, Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology, Centre for Cancer Biology at SA Pathology, Adelaide, South Australia

 

Professor Sue Branford is Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology at SA Pathology. She is a National Health and Medical Research Council Research Fellow and leads the International Chronic Myeloid Leukaemia Genomics Alliance. Learn about her journey and outstanding accolades, and her contributions to fighting blood cancer.

 

Sue Branford, Head of the Leukaemia Lab in the Department
Sue Branford, Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology, Centre for Cancer Biology at SA Pathology, Adelaide, South Australia

Discover QIAGEN's Sample to Insight oncohematology solutions

We support your path to personalized blood cancer care and advances in molecular research, with a comprehensive assay, platform and service portfolio. In addition, with broad expertise in IVD development and global regulatory and commercialization capabilities, QIAGEN is your partner for blood cancer companion diagnostics.

icon-learn
Need some help?
Contact us to learn more on our blood cancer solution
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm